Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +51.20%
#3 Siren Siren +26.90%
#4 Pons Pons +22.87%
#5 Main Street Yield Main Street Yield +17.48%
#6 龙虾 (Lobster) 龙虾 (Lobster) +15.82%
#7 Nillion Nillion +14.76%
#8 Collect on Fanable Collect on Fanable +14.29%
#9 Cysic Cysic +13.45%
#10 o1.exchange o1.exchange +13.41%
Coin of the day
GEKKO GEKKO
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Peringkat dalam Saham #7549
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Harga Saham
$34.73
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$1.54B
Perubahan (1 hari)
-4.89%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Healthcare
EPS untuk Avalyn Pharma Inc. Common Stock (AVLN)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Avalyn Pharma Inc. Common Stock, EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Avalyn Pharma Inc. Common Stock dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH